Two new antithrombin variants support a role for K114 and R13 in heparin binding
Open Access
- 1 February 2003
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (2) , 386-387
- https://doi.org/10.1046/j.1538-7836.2003.00048.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Lysine 114 of Antithrombin Is of Crucial Importance for the Affinity and Kinetics of Heparin Pentasaccharide BindingJournal of Biological Chemistry, 2001
- Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin geneBritish Journal of Haematology, 2000
- The anticoagulant activation of antithrombin by heparinProceedings of the National Academy of Sciences, 1997
- Identification of the Antithrombin III Heparin Binding SiteJournal of Biological Chemistry, 1997
- Lysine Residue 114 in Human Antithrombin III Is Required for Heparin Pentasaccharide-mediated ActivationJournal of Biological Chemistry, 1997
- Antithrombin Mutation Database: 2nd (1997) UpdateThrombosis and Haemostasis, 1997
- Congenital antithrombin III deficiencyThe American Journal of Medicine, 1989